{"id":"https://openalex.org/W2102472050","doi":"https://doi.org/10.1093/cid/cis339","title":"Antimicrobial Activities of Fidaxomicin","display_name":"Antimicrobial Activities of Fidaxomicin","publication_year":2012,"publication_date":"2012-07-02","ids":{"openalex":"https://openalex.org/W2102472050","doi":"https://doi.org/10.1093/cid/cis339","mag":"2102472050","pmid":"https://pubmed.ncbi.nlm.nih.gov/22752863","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3388021"},"language":"en","primary_location":{"id":"doi:10.1093/cid/cis339","doi":"https://doi.org/10.1093/cid/cis339","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/cis339","pdf_url":"https://academic.oup.com/cid/article-pdf/55/suppl_2/S143/20910983/cis339.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/cid/article-pdf/55/suppl_2/S143/20910983/cis339.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062693388","display_name":"Ellie J. C. Goldstein","orcid":"https://orcid.org/0000-0002-1044-6159","observed_orcids":["https://orcid.org/0000-0002-1044-6159"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ellie J. C. Goldstein","raw_affiliation_strings":["RM Alden Research Laboratory, Culver City, CA, USA. ejcgmd@aol.com","David Geffen School of Medicine, University of California, Los Angeles","RM Alden Research Laboratory, Culver City"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RM Alden Research Laboratory, Culver City, CA, USA. ejcgmd@aol.com","institution_ids":[]},{"raw_affiliation_string":"David Geffen School of Medicine, University of California, Los Angeles","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"RM Alden Research Laboratory, Culver City","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006964684","display_name":"Farah Babakhani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Farah Babakhani","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., San Diego, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053319026","display_name":"Diane M. Citron","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diane M. Citron","raw_affiliation_strings":["RM Alden Research Laboratory, Culver City"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RM Alden Research Laboratory, Culver City","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062693388"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":{"value":4763,"currency":"USD","value_usd":4763},"fwci":4.9502,"has_fulltext":true,"cited_by_count":95,"citation_normalized_percentile":{"value":0.95775862,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"55","issue":"suppl_2","first_page":"S143","last_page":"S148"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fidaxomicin","display_name":"fidaxomicin","score":1.0},{"id":"https://openalex.org/keywords/clostridioides-difficile","display_name":"Clostridium difficile","score":0.9319999814033508},{"id":"https://openalex.org/keywords/antimicrobial-activity","display_name":"antimicrobial activity","score":0.7049999833106995},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.972000002861023},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.6179999709129333},{"id":"https://openalex.org/keywords/bactericidal-activity","display_name":"bactericidal activity","score":0.6119999885559082},{"id":"https://openalex.org/keywords/gram-negative-aerobes","display_name":"gram-negative aerobes","score":0.6679999828338623},{"id":"https://openalex.org/keywords/anaerobic-bacteria","display_name":"anaerobic bacteria","score":0.828000009059906},{"id":"https://openalex.org/keywords/yeast","display_name":"yeast","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C2781342628","wikidata":"https://www.wikidata.org/wiki/Q5446672","display_name":"Fidaxomicin","level":5,"score":0.9867216944694519},{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.7098149657249451},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.7049121260643005},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.6835587024688721},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6522243022918701},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.5667527914047241},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3034049868583679},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.2340732216835022},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22894883155822754},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.1751524806022644},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077732","descriptor_name":"Fidaxomicin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000617","descriptor_name":"Aminoglycosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003015","descriptor_name":"Clostridium Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005243","descriptor_name":"Feces","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014640","descriptor_name":"Vancomycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/cid/cis339","doi":"https://doi.org/10.1093/cid/cis339","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/cis339","pdf_url":"https://academic.oup.com/cid/article-pdf/55/suppl_2/S143/20910983/cis339.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3388021","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3388021","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Infect Dis","raw_type":"Text"},{"id":"pmid:22752863","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22752863","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.789.9588","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.789.9588","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/c1/34/cis339.PMC3388021.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1093/cid/cis339","doi":"https://doi.org/10.1093/cid/cis339","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/cis339","pdf_url":"https://academic.oup.com/cid/article-pdf/55/suppl_2/S143/20910983/cis339.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308617","display_name":"Viropharma","ror":null},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320333684","display_name":"Sanofi Pasteur","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2102472050.pdf","grobid_xml":"https://content.openalex.org/works/W2102472050.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W2009016493","https://openalex.org/W2044370864","https://openalex.org/W2097250061","https://openalex.org/W2098455823","https://openalex.org/W2104141482","https://openalex.org/W2107652598","https://openalex.org/W2138430214","https://openalex.org/W2139754977","https://openalex.org/W2149991888","https://openalex.org/W2154774987","https://openalex.org/W2156646748","https://openalex.org/W2156891220","https://openalex.org/W2159964969","https://openalex.org/W2164025050","https://openalex.org/W2516700361","https://openalex.org/W2743041357"],"related_works":["https://openalex.org/W2614646941","https://openalex.org/W2785462207","https://openalex.org/W2006643884","https://openalex.org/W2333195366","https://openalex.org/W2332407663","https://openalex.org/W2217917186","https://openalex.org/W2154774987","https://openalex.org/W2724533416","https://openalex.org/W2142068286","https://openalex.org/W2979591527"],"abstract_inverted_index":{"Fidaxomicin":[0,151],"is":[1],"bactericidal":[2],"against":[3,157],"Clostridium":[4],"difficile.":[5],"The":[6],"combined":[7],"results":[8],"of":[9,14,26,39,41,44,58,69,96,102,116,118,120,126,139],"8":[10,127],"in":[11,80,130],"vitro":[12],"studies":[13],"1323":[15],"C.":[16,70],"difficile":[17,71],"isolates":[18,60],"showed":[19],"the":[20,100],"minimum":[21],"inhibitory":[22],"concentration":[23],"(MIC)":[24],"range":[25],"fidaxomicin":[27,56,76,149],"to":[28,75,144],"be":[29],"\u2264":[30],"0.001-1":[31],"\u03bcg/mL,":[32],"with":[33],"a":[34,84,89,108],"maximum":[35],"MIC":[36,95,113],"for":[37,114],"inhibition":[38,115],"90%":[40],"organisms":[42,119],"(MIC(90))":[43],"0.5":[45],"\u03bcg/mL.":[46,128],"Isolates":[47],"from":[48,88],"2":[49],"phase":[50],"III":[51],"clinical":[52,64],"trials":[53],"demonstrated":[54],"that":[55],"MICs":[57],"baseline":[59],"did":[61],"not":[62],"predict":[63],"cure,":[65],"failure,":[66],"or":[67,136,141,154,162],"recurrence":[68],"infections.":[72],"No":[73],"resistance":[74],"developed":[77],"during":[78],"treatment":[79],"either":[81],"study,":[82],"although":[83],"single":[85],"strain":[86],"recovered":[87],"cured":[90],"patient":[91],"had":[92,111],"an":[93,112,124],"elevated":[94],"16":[97],"\u00b5g/mL":[98],"at":[99],"time":[101],"recurrence.":[103],"For":[104],"135":[105],"strains,":[106],"OP-1118,":[107],"major":[109],"metabolite,":[110],"50%":[117],"4":[121],"\u03bcg/mL":[122],"and":[123,160],"MIC(90)":[125],"Changes":[129],"inoculum":[131],"size":[132],"(10(2)-10(5)":[133],"colony-forming":[134],"units/spot)":[135],"cation":[137],"concentrations":[138],"calcium":[140],"magnesium":[142],"appeared":[143],"have":[145],"no":[146,155],"effect":[147],"on":[148],"MICs.":[150],"has":[152],"little":[153],"activity":[156],"gram-negative":[158],"aerobes":[159],"anaerobes":[161],"yeast.":[163]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}